Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 71

1.

Impacts of platelet-rich fibrin and platelet-rich plasma on primary osteoblast adhesion onto titanium implants in a bisphosphonate in vitro model.

Steller D, Herbst N, Pries R, Juhl D, Klinger M, Hakim SG.

J Oral Pathol Med. 2019 Aug 10. doi: 10.1111/jop.12944. [Epub ahead of print]

PMID:
31400171
2.
3.

Impact of incubation method on the release of growth factors in non-Ca2+-activated PRP, Ca2+-activated PRP, PRF and A-PRF.

Steller D, Herbst N, Pries R, Juhl D, Hakim SG.

J Craniomaxillofac Surg. 2019 Feb;47(2):365-372. doi: 10.1016/j.jcms.2018.10.017. Epub 2018 Nov 15.

PMID:
30578012
4.

1,8-cineol inhibits the Wnt/β-catenin signaling pathway through GSK-3 dephosphorylation in nasal polyps of chronic rhinosinusitis patients.

Bruchhage KL, Koennecke M, Drenckhan M, Plötze-Martin K, Pries R, Wollenberg B.

Eur J Pharmacol. 2018 Sep 15;835:140-146. doi: 10.1016/j.ejphar.2018.07.060. Epub 2018 Aug 3.

PMID:
30081034
5.

Inhibition of GSK3α/β impairs the progression of HNSCC.

Schulz L, Pries R, Lanka AS, Drenckhan M, Rades D, Wollenberg B.

Oncotarget. 2018 Jun 12;9(45):27630-27644. doi: 10.18632/oncotarget.25250. eCollection 2018 Jun 12.

6.

PD-L1 is expressed on human platelets and is affected by immune checkpoint therapy.

Rolfes V, Idel C, Pries R, Plötze-Martin K, Habermann J, Gemoll T, Bohnet S, Latz E, Ribbat-Idel J, Franklin BS, Wollenberg B.

Oncotarget. 2018 Jun 8;9(44):27460-27470. doi: 10.18632/oncotarget.25446. eCollection 2018 Jun 8.

7.

Increased phosphorylation of eNOS in nasal polyps of chronic rhinosinusitis patients can be diminished by 1,8-cineol.

Koennecke M, Benecke F, Masche A, Linke R, Bruchhage KL, Pries R, Klimek L, Wollenberg B.

Nitric Oxide. 2018 Aug 1;78:89-94. doi: 10.1016/j.niox.2018.06.002. Epub 2018 Jun 6.

PMID:
29885366
8.

Pathogenetic and Clinical Aspects of Anti-Neutrophil Cytoplasmic Autoantibody-Associated Vasculitides.

Lamprecht P, Kerstein A, Klapa S, Schinke S, Karsten CM, Yu X, Ehlers M, Epplen JT, Holl-Ulrich K, Wiech T, Kalies K, Lange T, Laudien M, Laskay T, Gemoll T, Schumacher U, Ullrich S, Busch H, Ibrahim S, Fischer N, Hasselbacher K, Pries R, Petersen F, Weppner G, Manz R, Humrich JY, Nieberding R, Riemekasten G, Müller A.

Front Immunol. 2018 Apr 9;9:680. doi: 10.3389/fimmu.2018.00680. eCollection 2018. Review.

9.

[Regulatory dysfunctions in nasal polyposis].

Koennecke M, Pries R, Wollenberg B.

HNO. 2018 Apr;66(4):290-295. doi: 10.1007/s00106-018-0497-2. Review. German.

PMID:
29511778
10.

IL-10 in the microenvironment of HNSCC inhibits the CpG ODN induced IFN-α secretion of pDCs.

Bruchhage KL, Heinrichs S, Wollenberg B, Pries R.

Oncol Lett. 2018 Mar;15(3):3985-3990. doi: 10.3892/ol.2018.7772. Epub 2018 Jan 11.

11.

Synopsis of the 2017 U.S. Department of Veterans Affairs/U.S. Department of Defense Clinical Practice Guideline: Management of Type 2 Diabetes Mellitus.

Conlin PR, Colburn J, Aron D, Pries RM, Tschanz MP, Pogach L.

Ann Intern Med. 2017 Nov 7;167(9):655-663. doi: 10.7326/M17-1362. Epub 2017 Oct 24.

PMID:
29059687
12.

TGF-β1-induced cell migration in pancreatic carcinoma cells is RAC1 and NOX4-dependent and requires RAC1 and NOX4-dependent activation of p38 MAPK.

Witte D, Bartscht T, Kaufmann R, Pries R, Settmacher U, Lehnert H, Ungefroren H.

Oncol Rep. 2017 Dec;38(6):3693-3701. doi: 10.3892/or.2017.6027. Epub 2017 Oct 12.

PMID:
29039574
13.

Protein levels of clusterin and glutathione synthetase in platelets allow for early detection of colorectal cancer.

Strohkamp S, Gemoll T, Humborg S, Hartwig S, Lehr S, Freitag-Wolf S, Becker S, Franzén B, Pries R, Wollenberg B, Roblick UJ, Bruch HP, Keck T, Auer G, Habermann JK.

Cell Mol Life Sci. 2018 Jan;75(2):323-334. doi: 10.1007/s00018-017-2631-9. Epub 2017 Aug 28.

PMID:
28849249
14.

Inhibitory Effect of 1,8-Cineol on β-Catenin Regulation, WNT11 Expression, and Cellular Progression in HNSCC.

Roettger A, Bruchhage KL, Drenckhan M, Ploetze-Martin K, Pries R, Wollenberg B.

Front Oncol. 2017 May 22;7:92. doi: 10.3389/fonc.2017.00092. eCollection 2017.

15.

Neuronal Differentiation Capability of Nasal Polyps of Chronic Rhinosinusitis.

Koennecke M, Böscke R, Pfannerstill AC, Reers S, Elsner M, Fell B, Richter A, Bruchhage KL, Schumann S, Pries R, Klimek L, Wollenberg B.

Arch Immunol Ther Exp (Warsz). 2017 Oct;65(5):431-443. doi: 10.1007/s00005-017-0456-8. Epub 2017 Mar 9.

PMID:
28280847
16.

Wnt Signaling in Chronic Rhinosinusitis with Nasal Polyps.

Böscke R, Vladar EK, Könnecke M, Hüsing B, Linke R, Pries R, Reiling N, Axelrod JD, Nayak JV, Wollenberg B.

Am J Respir Cell Mol Biol. 2017 May;56(5):575-584. doi: 10.1165/rcmb.2016-0024OC.

17.

Epithelial-Mesenchymal Transition in Chronic Rhinosinusitis: Differences Revealed Between Epithelial Cells from Nasal Polyps and Inferior Turbinates.

Könnecke M, Burmeister M, Pries R, Böscke R, Bruchhage KL, Ungefroren H, Klimek L, Wollenberg B.

Arch Immunol Ther Exp (Warsz). 2017 Apr;65(2):157-173. doi: 10.1007/s00005-016-0409-7. Epub 2016 Jul 8.

PMID:
27393708
18.

Effects of paclitaxel on permanent head and neck squamous cell carcinoma cell lines and identification of anti-apoptotic caspase 9b.

Maushagen R, Reers S, Pfannerstill AC, Hahlbrock A, Stauber R, Rahmanzadeh R, Rades D, Pries R, Wollenberg B.

J Cancer Res Clin Oncol. 2016 Jun;142(6):1261-71. doi: 10.1007/s00432-016-2150-3. Epub 2016 Apr 1.

PMID:
27038158
19.

[Chemotherapy with paclitaxel leads to microRNA release].

Maushagen R, Pries R, Wollenberg B.

HNO. 2015 Nov;63(11):792-6. doi: 10.1007/s00106-015-0080-z. German.

PMID:
26464363
20.

Increased phosphorylation of STAT5b, but not STAT5a, in nasal polyps.

Linke R, Pries R, Könnecke M, Bruchhage KL, Böscke R, Gebhard M, Wollenberg B.

Am J Rhinol Allergy. 2015 May-Jun;29(3):182-7. doi: 10.2500/ajra.2015.29.4170.

PMID:
25975249
21.

Biological impact of superparamagnetic iron oxide nanoparticles for magnetic particle imaging of head and neck cancer cells.

Lindemann A, Lüdtke-Buzug K, Fräderich BM, Gräfe K, Pries R, Wollenberg B.

Int J Nanomedicine. 2014 Oct 29;9:5025-40. doi: 10.2147/IJN.S63873. eCollection 2014.

22.

Immune imbalance in nasal polyps of Caucasian chronic rhinosinusitis patients is associated with a downregulation of E-selectin.

Könnecke M, Böscke R, Waldmann A, Bruchhage KL, Linke R, Pries R, Wollenberg B.

J Immunol Res. 2014;2014:959854. doi: 10.1155/2014/959854. Epub 2014 Jun 3.

23.

The complement receptors CD46, CD55 and CD59 are regulated by the tumour microenvironment of head and neck cancer to facilitate escape of complement attack.

Kesselring R, Thiel A, Pries R, Fichtner-Feigl S, Brunner S, Seidel P, Bruchhage KL, Wollenberg B.

Eur J Cancer. 2014 Aug;50(12):2152-61. doi: 10.1016/j.ejca.2014.05.005. Epub 2014 Jun 7.

PMID:
24915776
24.

The MEK1/2-ERK1/2 pathway is activated in chronic rhinosinusitis with nasal polyps.

Linke R, Pries R, Könnecke M, Bruchhage KL, Böscke R, Gebhard M, Wollenberg B.

Arch Immunol Ther Exp (Warsz). 2014 Jun;62(3):217-29. doi: 10.1007/s00005-014-0281-2. Epub 2014 Mar 9.

PMID:
24609540
25.

Stem cell profiling in head and neck cancer reveals an Oct-4 expressing subpopulation with properties of chemoresistance.

Reers S, Pfannerstill AC, Maushagen R, Pries R, Wollenberg B.

Oral Oncol. 2014 Mar;50(3):155-62. doi: 10.1016/j.oraloncology.2013.12.006. Epub 2013 Dec 31.

PMID:
24387977
26.

Increased activation and differentiated localization of native and phosphorylated STAT3 in nasal polyps.

Linke R, Pries R, Könnecke M, Bruchhage KL, Böscke R, Gebhard M, Wollenberg B.

Int Arch Allergy Immunol. 2013;162(4):290-8. doi: 10.1159/000353893. Epub 2013 Oct 18.

27.

Decline of lactate in tumor tissue after ketogenic diet: in vivo microdialysis study in patients with head and neck cancer.

Schroeder U, Himpe B, Pries R, Vonthein R, Nitsch S, Wollenberg B.

Nutr Cancer. 2013;65(6):843-9. doi: 10.1080/01635581.2013.804579.

PMID:
23909728
28.

Cytokine changes in response to radio-/chemotherapeutic treatment in head and neck cancer.

Reers S, Pfannerstill AC, Rades D, Maushagen R, Andratschke M, Pries R, Wollenberg B.

Anticancer Res. 2013 Jun;33(6):2481-9.

PMID:
23749899
29.

CpG-Induced IFN-α production of plasmacytoid dendritic cells: time and dosage dependence and the effect of structural modifications to the CpG backbone.

Jeske S, Pries R, Wollenberg B.

Nucleic Acid Ther. 2013 Apr;23(2):118-24. doi: 10.1089/nat.2012.0384. Epub 2013 Feb 15.

PMID:
23414178
30.

Glycogen synthase kinase 3 in chronic rhinosinusitis: two faces of a single enzyme in one disease.

Linke R, Pries R, Könnecke M, Bruchhage KL, Böscke R, Gebhard M, Wollenberg B.

Ann Allergy Asthma Immunol. 2013 Feb;110(2):101-6. doi: 10.1016/j.anai.2012.11.016. Epub 2012 Dec 17.

PMID:
23352529
31.

Functional characterization of novel mutations affecting survivin (BIRC5)-mediated therapy resistance in head and neck cancer patients.

Knauer SK, Unruhe B, Karczewski S, Hecht R, Fetz V, Bier C, Friedl S, Wollenberg B, Pries R, Habtemichael N, Heinrich UR, Stauber RH.

Hum Mutat. 2013 Feb;34(2):395-404. doi: 10.1002/humu.22249. Epub 2012 Dec 20.

PMID:
23161837
32.

Pancreatic carcinoma cell lines reflect frequency and variability of cancer stem cell markers in clinical tissue.

Bünger S, Barow M, Thorns C, Freitag-Wolf S, Danner S, Tiede S, Pries R, Görg S, Bruch HP, Roblick UJ, Kruse C, Habermann JK.

Eur Surg Res. 2012;49(2):88-98. doi: 10.1159/000341669. Epub 2012 Aug 30.

PMID:
22948659
33.
34.

A novel xenogeneic co-culture system to examine neuronal differentiation capability of various adult human stem cells.

Petschnik AE, Fell B, Tiede S, Habermann JK, Pries R, Kruse C, Danner S.

PLoS One. 2011;6(9):e24944. doi: 10.1371/journal.pone.0024944. Epub 2011 Sep 14.

35.

Established and novel NF-κB inhibitors lead to downregulation of TLR3 and the proliferation and cytokine secretion in HNSCC.

Meyer C, Pries R, Wollenberg B.

Oral Oncol. 2011 Sep;47(9):818-26. doi: 10.1016/j.oraloncology.2011.06.010. Epub 2011 Jul 13.

PMID:
21745758
36.

Plasmacytoid dendritic cell subpopulations in head and neck squamous cell carcinoma.

Thiel A, Kesselring R, Pries R, Wittkopf N, Puzik A, Wollenberg B.

Oncol Rep. 2011 Sep;26(3):615-20. doi: 10.3892/or.2011.1350. Epub 2011 Jun 17.

PMID:
21687955
37.

The number of CD161 positive Th17 cells are decreased in head and neck cancer patients.

Kesselring R, Thiel A, Pries R, Wollenberg B.

Cell Immunol. 2011;269(2):74-7. doi: 10.1016/j.cellimm.2011.03.026. Epub 2011 Apr 9.

PMID:
21570678
38.

Expression of the T cell receptor αβ on a CD123+ BDCA2+ HLA-DR+ subpopulation in head and neck squamous cell carcinoma.

Thiel A, Kesselring R, Pries R, Puzik A, Wittkopf N, Wollenberg B.

PLoS One. 2011 Jan 11;6(1):e15997. doi: 10.1371/journal.pone.0015997.

39.

mTOR inhibitors show promising in vitro activity in bladder cancer and head and neck squamous cell carcinoma.

Schedel F, Pries R, Thode B, Wollmann B, Wulff S, Jocham D, Wollenberg B, Kausch I.

Oncol Rep. 2011 Mar;25(3):763-8. doi: 10.3892/or.2011.1146. Epub 2011 Jan 14.

PMID:
21240463
40.

Human Th17 cells can be induced through head and neck cancer and have a functional impact on HNSCC development.

Kesselring R, Thiel A, Pries R, Trenkle T, Wollenberg B.

Br J Cancer. 2010 Oct 12;103(8):1245-54. doi: 10.1038/sj.bjc.6605891. Epub 2010 Sep 28.

41.

Permanent up-regulation of regulatory T-lymphocytes in patients with head and neck cancer.

Schott AK, Pries R, Wollenberg B.

Int J Mol Med. 2010 Jul;26(1):67-75.

PMID:
20514424
42.

Cytokine release of human NK cells solely triggered with Poly I:C.

Wulff S, Pries R, Wollenberg B.

Cell Immunol. 2010;263(2):135-7. doi: 10.1016/j.cellimm.2010.03.020. Epub 2010 Apr 4.

PMID:
20427039
43.

Tumour-derived prostaglandin E and transforming growth factor-beta synergize to inhibit plasmacytoid dendritic cell-derived interferon-alpha.

Bekeredjian-Ding I, Schäfer M, Hartmann E, Pries R, Parcina M, Schneider P, Giese T, Endres S, Wollenberg B, Hartmann G.

Immunology. 2009 Nov;128(3):439-50. doi: 10.1111/j.1365-2567.2009.03134.x.

44.

Nanoparticel labelling of stem cell populations in head and neck cancer.

Lindemann A, Lüdtke-Buzug K, Hüsing B, Pries R, Buzug TM, Wollenberg B.

J Stem Cells Regen Med. 2010 Oct 23;6(2):143. eCollection 2010. No abstract available.

PMID:
24693151
45.

Stem cell characteristics in Polyposis nasi.

Könnecke M, Böscke R, Pries R, Wollenberg B.

J Stem Cells Regen Med. 2010 Oct 23;6(2):109. eCollection 2010. No abstract available.

PMID:
24693123
46.

Chemoresistance and apoptosis induction in head and neck squamous cell carcinoma.

Maushagen R, Pries R, Wollenberg B.

J Stem Cells Regen Med. 2010 Oct 23;6(2):108. eCollection 2010. No abstract available.

PMID:
24693122
47.

Decreased levels of circulating regulatory NK cells in patients with head and neck cancer throughout all tumor stages.

Wulff S, Pries R, Börngen K, Trenkle T, Wollenberg B.

Anticancer Res. 2009 Aug;29(8):3053-7.

48.
49.

In vivo studies on the availability and toxicity of antisense oligonucleotides in bladder cancer.

Blietz CE, Thode B, Hauses M, Pries R, Meyer AJ, Doehn C, Jocham D, Kausch I.

In Vivo. 2009 Jan-Feb;23(1):13-9.

50.

Toll-like receptor modulation in head and neck cancer.

Pries R, Wulff S, Wollenberg B.

Crit Rev Immunol. 2008;28(3):201-13. Review.

PMID:
19024345

Supplemental Content

Support Center